Literature DB >> 6189835

Fractionation and characterization of human small nuclear ribonucleoproteins containing U1 and U2 RNAs.

C S Kinlaw, B L Robberson, S M Berget.   

Abstract

Human small nuclear ribonucleoproteins (snRNPs) containing U1 and U2 snRNAs have been isolated from cultured cells by nonimmunological methods. The U1 snRNP population remained immunoprecipitable by systemic lupus erythematosis anti-RNP and anti-Sm antibodies throughout fractionation and contained polypeptides of molecular weights corresponding to those defined as U1 snRNP polypeptides by immunoprecipitation of crude extracts. The purified assemblies contained U1 RNA and nine snRNP polypeptides of molecular weights 67,000 (P67), 30,000 (P30), 23,000 (P23), 21,500 (P22), 17,500 (P18), 12,300 (P12), 10,200 (P10), 9,100 (P9), and 8,500 (P8). P67, P30, and P18 were unique to U1 snRNPs. The U2 snRNP population remained immunoprecipitable by the systemic lupus erythematosis anti-Sm antibody throughout fractionation. The purified U2 assemblies contained six polypeptides of molecular weights corresponding to those defined by immunoprecipitation to be common to U1 and U2 snRNPs including P23, P22, P12, P10, P9, and P8. In addition, U2 snRNPs contained a unique polypeptide of 27,000 Da.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  U1 small nuclear ribonucleoprotein particle-specific proteins interact with the first and second stem-loops of U1 RNA, with the A protein binding directly to the RNA independently of the 70K and Sm proteins.

Authors:  J R Patton; W Habets; W J van Venrooij; T Pederson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  Multiple splicing factors are released from endogenous complexes during in vitro pre-mRNA splicing.

Authors:  G C Conway; A R Krainer; D L Spector; R J Roberts
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

3.  Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides.

Authors:  D G Williams; M R Stocks; P R Smith; R N Maini
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.

Authors:  J Craft; T Mimori; T L Olsen; J A Hardin
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

5.  Reconstitution of the U1 small nuclear ribonucleoprotein particle.

Authors:  J R Patton; R J Patterson; T Pederson
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

6.  U1, U2, and U6 small nuclear ribonucleoproteins (snRNPs) are associated with large nuclear RNP particles containing transcripts of an amplified gene in vivo.

Authors:  R Sperling; P Spann; D Offen; J Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Antibodies to hnRNP core proteins inhibit in vitro splicing of human beta-globin pre-mRNA.

Authors:  H Sierakowska; W Szer; P J Furdon; R Kole
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

8.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

9.  Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.

Authors:  K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

10.  Individual variation of anti-Sm autoantibodies in the MRL/MP-lpr/lpr mouse: age-related increase in diversity.

Authors:  D G Williams; F M Brennan; M R Stocks; R N Maini
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.